Queen’s University Belfast
Ken Mills is the Chair of Experimental Hematology in the Centre for Cancer Research and Cell Biology (CCRCB) in Queen’s University Belfast. He coordinates the activities of the Blood Cancer Research Group with a focus on the molecular aspects of MDS and AML to identify novel therapies. He has published over 135 papers, several book chapters and he is on several Editorial Board and a regular Reviewer for high impact journals and national and international funding bodies.
Hematology, Blood Cancer Research, Molecular aspects of MDS